Carol Overton Tacket MD
Adjunct Professor, Internal Medicine, University of Maryland School of Medicine
Join to View Full Profile
271 Peat Bog LanePasadena, MD 21122
Phone+1 410-360-6936
Dr. Tacket is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Infectious Disease, 1983 - 1986
Yale-New Haven Medical CenterResidency, Internal Medicine, 1978 - 1981
Yale School of MedicineClass of 1978
Certifications & Licensure
MD State Medical License 1986 - 2021
Clinical Trials
- A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
- Phase 1 Norwalk Vaccine Study Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 2530 citationsVaginal microbiome of reproductive-age womenJacques Ravel, Pawel Gajer, Zaid Abdo, G. Maria Schneider, Sara S. K. Koenig
Proceedings of the National Academy of Sciences of the United States of America. 2011-03-15 - 42 citationsOral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+ IgD−S. Typhi ...Rezwanul Wahid, Marcela F. Pasetti, Milton Maciel, Jakub K. Simon, Carol O. Tacket
Clinical Immunology. 2011-02-01 - 153 citationsAdjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymp...Samer S. El-Kamary, Marcela F. Pasetti, Paul M. Mendelman, Sharon E. Frey, David I. Bernstein
The Journal of Infectious Diseases. 2010-12-01
Grant Support
- Clinical Trial: Phase I Study Of Intranasal Norwalk VLP Vaccine With Adjuvant &National Center For Research Resources2008–2009
- Clinical Trial: Phase I Prime-Boost Study Of VI Polysaccharide Typhoid Vaccine ANational Center For Research Resources2008–2009
- Plant Based Microbicides And Vaccines To Prevent StisNational Institute Of Allergy And Infectious Diseases2004–2008
- Phase I Randomized, Double-Blind Heterologous Prime Boost Study Of The Safety &9National Center For Research Resources2007
- Prime-Boost Study Of VI Typhoid Vaccine And Oral Typhoid Vaccine Strain CVD 909National Center For Research Resources2006
- Planning Grants For Institutional Clinical And Translational Science AwardsNational Center For Research Resources2006
- Cholera 47000: Use Of In Vivo Expression Technology To Identify Virulence FactoNational Center For Research Resources2005
- Safety/Pharmacokinetics Of Castx2 In HealthNational Center For Research Resources2004
- Mucosal Immunity And Oral Tolerance--Innate ImmunityNational Institute Of Allergy And Infectious Diseases2000–2001
- Enteric Pathogens - Mucosal Research UnitNational Institute Of Allergy And Infectious Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
